Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
side effects
Biotech
Patient suffers side effect in Cabaletta CAR-T trial
Analysts appeared unfazed by the news that a patient treated with Cabaletta Bio’s autoimmune CAR-T suffered a toxicity complication.
James Waldron
Apr 2, 2025 6:55am
Septerna drops lead asset over side effects 4 months after IPO
Feb 18, 2025 9:43am
Merck stops phase 3 TIGIT trial in lung cancer for futility
Aug 8, 2024 7:49am
Monopar spikes chemo side effect drug after phase 2/3 analysis
Mar 28, 2023 11:33am
Novartis suspends dosing in phase 2b Huntington's disease trial
Aug 24, 2022 1:03pm
A fix to PI3K cancer drugs' immune toxicity?
May 4, 2022 11:00am
